cancer

Kura Oncology’s Small Molecules Hint at Major Therapeutic Breakthroughs
Kura Oncology’s Small Molecules Hint at Major Therapeutic Breakthroughs
BioSpace
cancer
oncology
Kura Oncology
personalized medicine
Flag link:
The Future of Cancer Treatment Lies in Vaccines, Say These Pioneers
The Future of Cancer Treatment Lies in Vaccines, Say These Pioneers
BioSpace
cancer
oncology
vaccines
cancer vaccines
Neuvogen
Lineage Therapeutics
BioNTech
Flag link:
Dana-Farber launches venture fund targeting incurable cancers
Dana-Farber launches venture fund targeting incurable cancers
BioPharma Dive
Dana-Farber
cancer
venture capital
funding
Flag link:
Two Cancer Companies Close Series A Rounds Netting $144 Million
Two Cancer Companies Close Series A Rounds Netting $144 Million
BioSpace
cancer
oncology
funding
Delfi Diagnostics
Elucida Oncology
Flag link:
JPM: Boehringer inks Enara deal to source 'dark antigens' for cancer immunotherapies
JPM: Boehringer inks Enara deal to source 'dark antigens' for cancer immunotherapies
Fierce Biotech
JPMHC 2021
Boehringer Ingelheim
Enara Bio
dark antigens
cancer
cancer vaccines
Flag link:
BeiGene, Novartis in pact to develop tislelizumab for cancer settings
BeiGene, Novartis in pact to develop tislelizumab for cancer settings
Seeking Alpha
Novartis
BeiGene
tiselizumab
cancer
drug development
Flag link:
AI Drug Discovery Startup Valo Raises $190 Million And Unveils Cancer Therapy Programs
AI Drug Discovery Startup Valo Raises $190 Million And Unveils Cancer Therapy Programs
Forbes
Valo Health
drug discovery
cancer
artificial intelligence
Flag link:
Two Companies Ring in 2021 with Cash for Cancer and Rare Diseases
Two Companies Ring in 2021 with Cash for Cancer and Rare Diseases
BioSpace
funding
biotech
IconOVir Bio
oncolytic viruses
cancer
oncology
Aro Biotherapeutics
RNA
Flag link:
Ikena bags $120M to advance growing pipeline of cancer drugs
Ikena bags $120M to advance growing pipeline of cancer drugs
Fierce Biotech
Ikena Oncology
cancer
oncology
funding
Flag link:
What if we captured the spirit and urgency of Covid-19 research to cure cancer?
What if we captured the spirit and urgency of Covid-19 research to cure cancer?
MedCity News
COVID-19
R&D
drug development
cancer
oncology
Flag link:
Agios, changing its identity, to sell cancer drug business to Servier
Agios, changing its identity, to sell cancer drug business to Servier
BioPharma Dive
Agios Pharmaceuticals
cancer
M&A
Servier
Flag link:
Janux pairs up with Merck for $1B-plus T-cell engager deal
Janux pairs up with Merck for $1B-plus T-cell engager deal
Fierce Biotech
Merck
Janux Therapeutics
R&D
T-cell engager
cancer
Flag link:
New antibody-drug conjugate partnership has oncology focus
New antibody-drug conjugate partnership has oncology focus
Biopharma Reporter
Sterling Pharma Solutions
CDMOs
oncology
cancer
antibody-drug conjugate
Flag link:
Covid-19 Is derailing cancer clinical trials. Is new technology required to get them back on track?
Covid-19 Is derailing cancer clinical trials. Is new technology required to get them back on track?
MedCity News
data automation
clinical trials
COVID-19
pandemic
cancer
oncology
Flag link:
Better Together – Merck KGaA Announces Collaboration with Artios
Better Together – Merck KGaA Announces Collaboration with Artios
BioSpace
Merck KGaA
Artios Pharma
drug development
cancer
oncology
Flag link:
FDA goes beyond the label to educate doctors—and enlighten others—about new cancer drugs
FDA goes beyond the label to educate doctors—and enlighten others—about new cancer drugs
Fierce Pharma
FDA
physicians
cancer
labeling
Flag link:
How Gilead finally spent its money
How Gilead finally spent its money
BioPharma Dive
Gilead Sciences
cancer
oncology
Flag link:
Fusion Pharma teams up with AstraZeneca in next-gen radiopharmaceuticals for cancer
Fusion Pharma teams up with AstraZeneca in next-gen radiopharmaceuticals for cancer
Seeking Alpha
AstraZeneca
Fusion Pharmaceuticals
radiopharmaceuticals
cancer
Flag link:
Patrick Soon-Shiong steps down as CEO of NantKwest, a linchpin of his 'Cancer Moonshot'
Patrick Soon-Shiong steps down as CEO of NantKwest, a linchpin of his 'Cancer Moonshot'
Endpoints
Patrick Soon-Shiong
NantKwest
cancer moonshot
cancer
biotech
Flag link:
What can a biotech entrepreneur and a top scientist come up with on a couple of shared flights? Well...
What can a biotech entrepreneur and a top scientist come up with on a couple of shared flights? Well...
Endpoints
Scorpion
cancer
small molecule drugs
precision medicine
Flag link:

Pages